In 2013, for the first time in history, a cure is found for Hepatitis C. It can save millions of lives, but priced between $40,000 and $84,000 for 84 pills in much of the western world, the medicine is almost impossible to access. In India, a generic version of the drug is available for less than $1000. Denied a cure that can save their lives, a group of patients take matters into their own hands and defy the American pharmaceutical company that holds the patent for this drug. Buyers Club charts their epic story, a story of global solidarity in the face of corporate greed.
